These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9534751)

  • 1. Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
    Scoular A; Barton S
    Genitourin Med; 1997 Oct; 73(5):391-3. PubMed ID: 9534751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Chibo D; Mijch A; Doherty R; Birch C
    J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital herpes. A guide to pharmacological therapy.
    de Ruiter A; Thin RN
    Drugs; 1994 Feb; 47(2):297-304. PubMed ID: 7512902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of genital herpes in HIV-infected patients.
    Aoki FY
    Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital herpes simplex virus infection in the adolescent: special considerations for management.
    Stanberry LR; Rosenthal SL
    Paediatr Drugs; 2002; 4(5):291-7. PubMed ID: 11994034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes study and resources.
    Treat Rev; 1997 Aug; (No 25):5. PubMed ID: 11364615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
    McGrath BJ; Newman CL
    Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
    Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
    Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment of genital herpes.
    Apoola A; Radcliffe K
    Int J STD AIDS; 2004 Jul; 15(7):429-33. PubMed ID: 15228725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
    Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
    Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
    Celum C; Wald A; Hughes J; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Casapia M; Ortiz A; Fuchs J; Buchbinder S; Koblin B; Zwerski S; Rose S; Wang J; Corey L;
    Lancet; 2008 Jun; 371(9630):2109-19. PubMed ID: 18572080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.